The clinical manifestations of sickle cell anemia in India seem to be milder than in Africa and Jamaica. Mostly homozygous sickle cell anemia patients seek treatment for vaso-occlusive crises, which have greatest incidence during the rainy season, followed by winter. It is interesting to note that both sickle cell anemia patients and carriers (heterozygotes) have iron deficiency. ␣ Thalassemia is one of the major epistatic factors responsible for amelioration of the disease. Simple measures like vaccination in childhood, adequate oral intake of fluids with electrolytes during vaso-occlusive crises, and avoidance of exposure to extreme temperatures reduce the number of patients with vaso-occlusive crises. Premarital counseling and prenatal diagnosis also help reduce the number of births of homozygous children. Curr Opin Hematol 2002 , 9:117-122 © 2002 Lippincott Williams & Wilkins, Inc.
With increasing control of infant mortality and infectious diseases in India, genetic diseases are assuming a proportionately greater importance in medical practice. Sickle cell disease (SCD) is the first genetic disorder studied at molecular level. Extensive knowledge has accumulated about various aspects of this disease. However, certain facets of SCD remain unexplored. The study of phenotype and genotype correlation has been scanty because of complex interactions among many genetic and environmental factors. Furthermore, the pathophysiology of sickling phenomenon remains a mystery in spite of extensive research. The proper treatment or therapy also remains uncertain. The hereditary anemias pose a considerable health burden in India. Among these, the ␤ thalassemias, sickle cell anemia, and hemoglobin E disease contribute significantly to morbidity and mortality. The only options for control of these diseases remain carrier detection, genetic counseling, and prenatal diagnosis for detection of affected fetuses. These measures provide a good community program for the control of SCD in India. This review focuses on newer aspects of the disease in India and intervention programs for its control.
Distribution of ␤ S gene in India
India is a vast country with many castes, tribes, languages, and religions. ␤ S gene is most often found among Dravidian and pre-Dravidian tribes; until recently, these tribes inhabited highly malaria-endemic regions where plasmodium falciparum was very common [1]. Lehman and Cutbush [2] were the first to report the presence of the ␤ S gene in the tribal groups of the Nilgiri Hills in southern India.
Distribution of the ␤ S gene in India is shown in Figure 1 . Approximately 300 population groups have been studied so far, and the prevalence rate varies from 0 to 34% in different groups [3] . The sickle cell gene is not confined to the tribal or scheduled caste populations, as originally believed; it has occasionally been reported in other populations, irrespective of tribe, caste, language, and geographical boundary [4, 5] .
Based on available information on the prevalence of the ␤ S gene, the number of sickle cell heterozygotes and homozygotes has been estimated: the astounding figures of 2,434,170 sickle heterozygotes and 121,375 sickle homozygotes in India. Madhya Pradesh has the most sickle homozygotes, followed by Gujarat, Maharashtra, Andhra Pradesh, and Orissa [6].
Severity of the disease and various clinical manifestations
In India, the major clinical manifestation among homozygotes is vaso-occlusive crisis, which seems to be universal throughout the country [7•,8]. Patients complain mostly of periodic pain all over the body or in joints and limbs. Some carriers of SCD also complain of painful crisis [7•,9••].
In the authors' ongoing study and other studies, it has been observed that this painful crisis has greatest incidence during the rainy season, followed by winter [10••]. The average survival rate of homozygous cases has been reported to be as long as 40 years [7•]. The authors' recent survey in two population groups with a high prevalence of the sickle cell gene, one tribal and one nontribal, revealed a diversity of clinical manifestations in the two groups. Tribal participants had a mild clinical course, whereas nontribal participants had a more severe clinical course (Table 1 ). The authors concluded that the phenotypic expression of sickle cell anemia is not uniformly mild, and ␣ thalassemia is a powerful epistatic factor in the Arab Indian haplotype [8] . Priapism and leg ulcers seem very uncommon in Indian patients [7•,8,11,12]. Of 383 patients in Nagpur, Maharashtra, 66% had splenomegaly and 10% had gallstones. Jaundice was seen in 52% of the patients, fever in approximately 40%, epistaxis in approximately 20%, and hematuria in 5% (Jain, Unpublished data, August 2001).
In a study from Orrisa, a similar incidence of gallstones was reported by ultrasound, but biliary colic seemed rare. The researchers observed that patients with gallstones had significantly lower hemoglobin F, had higher serum bilirubin, and suffered frequently from anemia and jaundice [13] .
The most common causative organism of infection in children younger than 5 years was pneumococcus and Gram-negative organisms. Raised in serum IgG and IgA levels and lowered C3 values were observed in sickle homozygous patients [14] . IgG4 seemed to be the predominant subtype in both heterozygous and homozygous patients [14a]. Delayed puberty and average menarche at 15.8 years compared with 13 years for healthy Indian women have also been observed. Another important finding, overlooked in the past, is childhood stroke in approximately 5.2% of patients (Jain, Unpublished data, August 2001). This finding causes a great deal of concern within the healthcare system. 
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The map shows the distribution of the ␤ S gene in different states. Note that it is more prevalent in the central and western regions. Figures in parentheses indicate the prevalence rate of the ␤ S gene.
Ghosh et al.
[15] investigated the incidence of splenomegaly and typical history of malaria over a period of 2 years in apparently healthy school children in a tribal area of Maharashtra to observe whether the incidence of malaria was different in children with sickle cell trait than in children with an AA hemoglobin pattern. Approximately 9.55% of the healthy population had either splenomegaly or a convincing history of malarial infection, not statistically different (P > 0.05) from the evidence of malaria in patients with sickle cell trait (8.79%). However, ␣ thalassemia and iron deficiency anemia were common in all children and all adults. The authors were surprised to find that of 25 sickle homozygotes studied, 24 had an increased free erythrocyte protoporphyrin (FEP) level. Acquired factors like iron deficiency could protect against malaria in addition to acquired immunity to this condition in endemic areas. The spleen rate (6.62%) in this population as a whole was certainly higher than in the general Indian population. 
Effects of ␣ thalassemia on sickle cell anemia
The effects of ␣ thalassemia on sickle red blood cells are well known [26] . In India, a prevalence of 70 to 95% of some form of ␣ thalassemia have been reported from the tribes of southern, central, and western India [8, [27] [28] [29] [30] [31] [32] .
In India, ␣ thalassemia renders the clinical manifestations of sickle cell anemia milder, with fewer episodes of painful crisis, chest syndromes, infections, hospitalizations, and blood transfusions ( Table 2 ). Splenomegaly is more common than in patients with a normal ␣-globin genotype [18] . Earlier studies indicated that splenomegaly was more common in Indian patients with sickle cell anemia than in Jamaican patients and was associated with higher hemoglobin F levels and a higher incidence of ␣ thalassemia with a milder clinical course. However, the impact of ␣ thalassemia on the severity of sickle cell disease was not convincingly demonstrated in this study [11] . It has also been showed that clinical manifestations of sickle cell anemia were influenced by ␣ thalassemia rather than the ␤ S haplotype or higher hemoglobin F levels in Indians [33••] . It is interesting to note that the presence of excess ␣ genes (␣␣␣ 3.7 /␣␣) in sickle cell heterozygotes could result in unusually severe clinical symptoms [9••].
Kulozik et al. [20] reported that ␣ thalassemia was more common in sickle cell patients 10 years old or older than in younger patients. The significantly greater ␣ gene frequency found among older patients may be caused by a notional effect of ␣ thalassemia delaying the onset of symptoms, but it may also suggest that ␣ thalassemia has a positive effect on the survival of patients with sickle cell anemia. However, the authors have not found any correlation between ␣ thalassemia and the survival of patients with sickle cell anemia (Mohanty and Mukherjee, Unpublished data, 2001).
Hemoglobin F levels in sickle cell disease and their effect on severity of disease
It has been established that hemoglobin F interferes with the polymerisation of hemoglobin S [34] and that, therefore, high levels of hemoglobin F have the potential to ameliorate the clinical course of SCD [35] . Higher hemoglobin F levels (2-36%) have been reported among patients with sickle cell anemia from different population groups of India [11, [36] [37] [38] .
In India, it has been reported that SCD in association with higher hemoglobin F levels tends to have less anemia and milder clinical manifestations [11, 36] . A study of the effect of hemoglobin F levels on severity of disease did not show significant correlation between hemoglobin F levels and clinical severity of the disease. Nevertheless, mean hemoglobin F levels were slightly high in the group of patients without history of painful crisis, infections, need for hospitalizations, or blood transfusions. Further, the levels of hemoglobin S were significantly lower when the hemoglobin F levels were high (> 10%) [39] . Similar observations were made in patients with sickle cell anemia from Madhya Pradesh and Orissa [40, 41] . Hemoglobin F levels may simply contribute to a milder clinical course along with other factors like associated ␣ thalassemia, changes in climatic conditions, and nutritional status. The phenotypic expression of sickle cell anemia with high levels of hemoglobin F and F cells is not uniformly mild in India [8] . Splenomegaly is more common in Indian patients with SCD and is found to be associated with high hemoglobin F levels [11, 39] . It is possible that the higher hemoglobin F levels seen in Indian cases help reduce the episodes of painful crisis but allow the spleen to enlarge as a result of compensatory ongoing mild hemolysis. Kulozik et al. [23] reported that Indian patients with SCD have a high prevalence of an independent, Swiss-type hereditary persistence of fetal hemoglobin determinant active in the sickle cell trait and in SCD.
Double heterozygosity
In India, there are sporadic reports of hemoglobin S-␤ thalassemia and hemoglobin SD [23, 38, [42] [43] [44] . The occurrence of sickle cell ␤ thalassemia is determined by the distribution and prevalence of the two abnormal genes. The prevalence of ␤ thalassemia in the tribal populations where sickle cell gene is very common was found to be low [5, 38, 45, 46] . In the authors' study of 12 patients with S␤-thalassemia, clinical manifestations were mild except 
G6PD deficiency in sickle cell disease
The association between hemoglobin S gene and G6PD deficiency has not been well documented. However, the authors' study [38] has shown the frequency of G6PD deficiency to be higher in sickle heterozygotes compared with healthy people.
Genetic counseling
The birth of a sickle cell homozygous child can be prevented by genetic counseling. The authors have initiated the genetic counseling by educating primary health care physicians and the tribal populations of Maharashtra, where sickle cell gene frequency is high. Pictorial cards explaining sickle cell status were distributed, and individual counseling was given to young, unmarried people to explain the danger of carrier-to-carrier marriages and the usefulness of blood testing before selecting a life partner. Married couples in which both partners were carriers of the hemoglobin S gene were counseled about prenatal diagnosis.
The authors' experience with the impact of genetic counseling is that people voluntarily test their blood for sickle cell status and seek prenatal diagnosis to avoid the birth of a child with SCD. However, prenatal diagnosis is expensive and is not available everywhere in India, so the success rate is not very high. It is interesting to note that couples from other regions come to the authors' center at Mumbai for prenatal diagnosis. So far, the authors have offered prenatal diagnosis to 16 couples by chorionic villus sampling in first trimester of pregnancy, and 10 fetuses were found to be sickle homozygotes.
The authors' experience showed that education about SCD has improved the quality of life of patients with SCD. Some voluntary organizations have already undertaken the sickle cell program on a regular basis as part of their social service campaign, especially in the tribal areas where sickle cell gene is highly prevalent.
The intervention program undertaken by the authors for the last 4 years in Maharashtra shows that simple measures like treatment of intestinal helminthiasis, vaccination with diphtheria, pertussis, and tetanus vaccine and bacille Calmette-Guérin vaccine, and administration of folic acid and electrolyte solution orally during painful crises reduce the rate of vaso-occlusive crisis from 5 or 6 per year to 2 or 3 per year. Patients also are advised not to expose themselves to extremes of temperature and to drink plenty of water during vaso-occlusive crises. The authors followed up 68 patients with SCD for a period of more than 1 year and found that 10%, the patients undergoing regular treatment, showed improvement. Four patients (5.8%) died. Except in one patient who devel-oped deep jaundice, it was very difficult to determine the causes of death.
Conclusions
The prevalence of the ␤ S gene (heterozygous and homozygous) varies from 0 to 34% in different population groups in India. The clinical manifestations of sickle homozygous, although variable, nevertheless seem to be milder than in African and Jamaican patients. One of the interesting findings in the present study is the prevalence of iron deficiency anemia in both sickle homozygous and heterozygous cases. ␤-globin gene cluster haplotype analysis revealed that the ␤ S gene is mainly linked to the typical Arab-Indian haplotype, suggesting a unicentric origin of ␤ S mutation in India. The major epistatic factor was found to be ␣-thalassemia, which plays a synergistic role in ameliorating the clinical severity of the disease. It is possible to reduce the birth rate of homozygous children through genetic counselling.
Simple intervention measures such as childhood vaccination, folic acid administration, and giving oral fluid and electrolytes during painful crisis help to improve the quality of life.
